Target Price | $6.63 |
Price | $3.71 |
Potential |
78.71%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2026 .
The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $6.63.
This is
78.71%
register free of charge
$10.50
183.02%
register free of charge
$6.06
63.34%
register free of charge
|
|
A rating was issued by 14 analysts: 13 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
78.71%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 7.87 | 34.07 |
332.96% | ||
Net Margin | -7,216.52% | -663.99% |
90.80% |
9 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
10 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.11 | -0.66 |
502.86% | 68.72% | |
P/E | negative | |
EV/Sales | 25.36 |
10 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Nuvation Bio Inc - Ordinary Shares - Class A...
Analyst | Rating | Action | Date |
---|---|---|---|
Jefferies |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 19 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Jun 25 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jun 17 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Jun 11 2025 |
Analyst Rating | Date |
---|---|
Locked
Jefferies:
Locked
➜
Locked
|
Sep 30 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 19 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Jun 25 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jun 17 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Jun 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.